Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (6): 1201-1204. doi: 10.19723/j.issn.1671-167X.2021.06.033

Previous Articles     Next Articles

Chronic kidney disease after adrenalectomy in a patient with primary aldosteronism

AN Wen-cheng1,YAN Hui-xian1,DENG Zheng-zhao2,CHEN Fang1,OU Xiao-hong1,JIN Hong-xin1,HUANG Wei1,()   

  1. 1. Department of Endocrinology, Beijing Haidian Hospital, Peking University Third Hospital (Haidian District), Beijing 100080, China
    2. Department of Endocrinology, Peking University Third Hospital, Beijing 100191, China
  • Received:2019-12-23 Online:2021-12-18 Published:2021-12-13
  • Contact: Wei HUANG E-mail:hdyynfm@163.com

RICH HTML

  

Abstract:

We report one case of estimated glomerular filtration rate (eGFR) decline after taking unilateral adrenalectomy due to aldosterone adenoma. A 60-year-old male with 23-year history of hypertension was reported to the endocrinologist due to hypokalemia (serum potassium 3.01 mmol/L). Urine microalbumin / creatinine (ALB/CR) was 70.15 mg/g, serum creatinine was 82 μmol/L and eGFR was 89.79 mL/(min·1.73 m 2). Random serum aldosterone was 172.2-203.5 ng/L, and random plasma rennin activity was 0-0.17 μg/(L·h). His captopril challenge test suggested that his aldosterone le-vels were suppressed by 8% (<30%) and the adrenal enhanced computed tomography scan revealed a left adrenal tumor. The patient was diagnosed with primary hyperaldosteronism (PA), aldosterone adenoma and underwent left laparoscopic adrenalectomy. Histological examination confirmed adrenal cortical adenoma. One week after the operation, his serum creatinine was increased to 127 μmol/L compared with preoperative level; eGFR was 32.34 mL/(min·1.73 m 2). His systolic blood pressure (SBP) was 110 mmHg and diastolic blood pressure (DBP) was 60 mmHg (hypotensive drugs discontinued), and serum potassium level was 5.22 mmol/L. At the end of the 2-year follow up, the serum creatinine of this patient remained at 109-158 μmol/L and eGFR fluctuated from 63.28-40.12 mL/(min·1.73 m 2). PA is one of the most common causes of secondary hypertension. Several studies have reported renal function deterioration of PA patients after unilateral adrenalectomy, like the patient in this article. Age, preoperative plasma aldosterone concentration, albuminuria and preoperative potassium level might be significant predictors of a decrease in the eGFR. Growing evidence suggests that aldosterone could contribute to structural kidney damage, arterial injury and hemodynamic disorder. At the same time, patients with PA exhibit glomerular hyperfiltration and glomerular vascular hypertension, leading to the misinterpretation of renal function in PA patients as subtle kidney damage may be masked by the glomerular hyperfiltration before treatment. After a unilateral adrenalectomy, glomerular hyperfiltration by aldosterone excess is resolved and renal damage can be unmasked. In conclusion, kidney function deterioration after adrenalectomy can be detected in some patients with PA. Thus, accurate evaluation of kidney function in patients with PA may be essential, especially for those with preoperative risk factors for postoperative renal impairment. After unilateral adrenalectomy, close monitoring of renal function and adequate management are required for PA patients.

Key words: Hyperaldosteronism, Adrenocortical adenoma, Adrenalectomy, Renal insufficiency, chronic

CLC Number: 

  • R586

Table 1

Results of postural stimulation test"

Inspection items Normal reference Postural stimulation test
1 2 3
Lying position (8:00 am)
Renin activity/[μg/(L·h)] 0.05-0.79 0.17 0 0.05
AngiotensinⅡ/(ng/L) 28.2-52.2 41.85 42.44 57.36
Aldosteronec/(ng/L) 59-174 199.65 194.94 220.15
Standing position (10:00 am)
Renin activity/[μg/(L·h)] 0.93-6.56 0.13 <0.10 0.16
AngiotensinⅡ/(ng/L) 55.3-115.3 51.54 39.78 55.66
Aldosterone/(ng/L) 65-296 223.92 203.59 225.90
ARR 172.2 203.5 141.2

Table 2

Results of captopril challenge test"

Items Before captopril test (8:00 am) After captopril test (10:00 am)
Renin activity/[μg/(L·h)] 0.14 <0.10
AngiotensinⅡ/ (ng/L) 49.32 61.50
Aldosterone / (ng/L) 215.60 197.22

Figure 1

Changes in eGFR levels during follow-up eGFR, estimated glomerular filtration rate."

[1] Hundemer GL, Curhan GC, Yozamp N, et al. Renal outcomes in medically and surgically treated primary aldosteronism[J]. Hypertension, 2018, 72(3):658-666.
doi: 10.1161/HYPERTENSIONAHA.118.11568 pmid: 29987110
[2] Park KS, Kim JH, Yang YS, et al. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism[J]. Endocr J, 2017, 64(6):623-632.
doi: 10.1507/endocrj.EJ16-0530
[3] Kanarek-Kucner J, Stefanski A, Barraclough R, et al. Insufficiency of the zona glomerulosa of the adrenal cortex and progressive kidney insufficiency following unilateral adrenalectomy: Case report and discussion[J]. Blood Press, 2018, 27(5):304-312.
doi: 10.1080/08037051.2018.1470460
[4] Utsumi T, Kawamura K, Imamoto T, et al. Preoperative masked renal damage in Japanese patients with primary aldosteronism: Identification of predictors for chronic kidney disease manifested after adrenalectomy[J]. Int J Urol, 2013, 20(7):685-691.
doi: 10.1111/iju.2013.20.issue-7
[5] Iwakura Y, Morimoto R, Kudo M, et al. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases[J]. J Clin Endocrinol Metab, 2014, 99(5):1593-1598.
doi: 10.1210/jc.2013-2180
[6] Sechi LA, Di Fabio A, Bazzocchi M, et al. Intrarenal hemodynamics in primary aldosteronism before and after treatment[J]. J Clin Endocrinol Metab, 2009, 94(4):1191-1197.
doi: 10.1210/jc.2008-2245
[7] Onohara T, Takagi T, Yoshida K, et al. Assessment of postoperative renal function after adrenalectomy in patients with primary aldosteronism[J]. Int J Urol, 2019, 26(2):229-233.
doi: 10.1111/iju.2019.26.issue-2
[8] Park SM, Jung WJ, Park JM, et al. Unmasked chronic renal function deterioration after unilateral adrenalectomy in patients with primary aldosteronism[J]. Kidney Res Clin Pract, 2016, 35(4):255-258.
pmid: 27957422
[9] Hollenberg NK. Aldosterone in the development and progression of renal injury[J]. Kidney Int, 2004, 66(1):1-9.
pmid: 15200407
[10] Briet M, Schiffrin EL. Aldosterone: Effects on the kidney and cardiovascular system[J]. Nat Rev Nephrol, 2010, 6(5):261-273.
doi: 10.1038/nrneph.2010.30
[11] Sechi LA, Novello M, Lapenna R, et al. Long-term renal outcomes in patients with primary aldosteronism[J]. JAMA, 2006, 295(22):2638-2645.
[1] Qingxin ZHOU,Qingqing YANG,Shuyuan SHI,Pei LI,Feng SUN. Association between serum uric acid and airflow obstruction based on the health-checkup population [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 693-699.
[2] Zi-kai WANG,Jia-li MO,Meng ZHANG,Ji-ping LIAO. Epidemiology and hospitalization costs analysis of female inpatients with acute exacerbation of chronic obstructive pulmonary disease in Beijing from 2013 to 2020 [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1074-1081.
[3] Hui-li LIU,Yan-han LV,Xiao-xiao WANG,Min LI. Factors influencing the chronic post-surgical pain after laparoscopic surgery for elderly patients with urinary tract tumors [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 851-856.
[4] Chun-su ZHU,Zhi-wei LIAN,Yi-min CUI. Association between depression and chronic diseases among middle-aged and older Chinese adults [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 606-611.
[5] Hai-hong JIANG,Xiao-fan LI,Jian-liu WANG. Relationship between chronic radiation enteritis of cervical cancer and gut microbiota [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 619-624.
[6] Xi-yan PEI,Wen YANG,Xiang-ying OUYANG,Feng SUN. Comparison of clinical effects between periodontal endoscopy aiding subgingival debridement and flap surgery [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 716-720.
[7] Xiao-xuan LIU,Shuo ZHANG,Yan MA,A-ping SUN,Ying-shuang ZHANG,Dong-sheng FAN. Diagnostic value of F wave changes in patients with Charcot-Marie-Tooth1A and chronic inflammatory demyelinating polyneuropathy [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 160-166.
[8] Lin MA,Jing-yi WU,Shuang-cheng LI,Peng-fei LI,Lu-xia ZHANG. Effect of modification of antihypertensive medications on the association of nitrogen dioxide long-term exposure and chronic kidney disease [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1047-1055.
[9] Ling-yi XU,Miao HUI,Shu-hong ZHU,Zhao YANG,Meng-rui LI,Hong-yu YANG,Xi-zi ZHENG,Ji-cheng LV,Li YANG. Chronic kidney disease in community: Current state for screening and management [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1056-封三.
[10] Lei-jie WANG,Ming-wei LI,Yan-na LIU,Xiang-mei CHEN,Jing-min ZHAO,Shu-hong LIU,Feng-min LU. Natural history and disease progression of chronic hepatitis B virus infection [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 920-926.
[11] Yu-chao HUANG-FU,Yi-qing DU,Lu-ping YU,Tao XU. Risk factors of persistent hypertension in primary aldosteronism patients after surgery [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 686-691.
[12] Guang-qi LIU,Yuan-jie PANG,Jiang WU,Min LV,Meng-ke YU,Yu-tong LI,Yang-mu HUANG. Trend analysis of influenza vaccination among hospitalized elderly people in Beijing, 2013-2019 [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 505-510.
[13] GAO Peng,LUO Yan-ping,LI Jun-feng,CHEN lin,MAO Xiao-rong. Effects of hepatitis B virus on Th17, Treg and Th17/Treg ratio in different alanine aminetransferase stages [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 272-277.
[14] DONG Bo,MA Xiao-wei,GUO Xiao-hui,GAO Ying,ZHANG Jun-qing. Clinical value of captopril test in noninvasive diagnosis of aldosterone-producing adenoma [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1128-1132.
[15] KANG Wen-yu,WANG Lu,QIU Min,ZHANG Fan,GUO Wei,QIANG Ya-yong,TUO Peng-fei,ZONG You-long,LIU Lei-lei,WANG Shuai-shuai. Adrenal cavernous hemangioma: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 808-810.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!